InvestorsHub Logo
icon url

HappyLibrarian

11/18/22 1:31 PM

#535139 RE: dr_lowenstein #535137

What do you mean by Us? Most shareholders are confident of at least the safety profile of the product (primarily a Phase 1 issue) or they would not be invested.

Go to NWBO’s website and they should have enough of a summary of the data. I sat through presentations back when NWBO still bothered to do them so I know the safety profile is good and certainly compared to the safety of just taking SOC and hoping you’ll be one of the less than 5% to make it. I am not going to regurgitate it for you.

Tacking on another 10 years just to get started with GBM is unacceptable and pushes other indications back even further and it is bad for the FDA, bad for patients and yes bad for us.